Matthew A Rowley

Activation of N-ras and K-ras induced by interleukin-6 in a myeloma cell line: implications for disease progression and therapeutic response

B. Ness, M. Rowley, Matthew A Rowley, 2002, Oncogene.

Heterogeneity in therapeutic response of genetically altered myeloma cell lines to interleukin 6, dexamethasone, doxorubicin, and melphalan.

B. V. Van Ness, P. Liu, M. Rowley, 2000, Blood.